Dataset from A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/PR00007827
下载链接
链接失效反馈官方服务：
资源简介：
24-week study to evaluate the efficacy and safety of macitentan for the treatment of
portopulmonary hypertension.
创建时间：
2024-11-26
